Company intelligence / Profile preview

Mainstay Medical

Ownership: Private
Development stage: Commercial

Overview

Mainstay Medical’s ReActiv8 Restorative Neurostimulation system has demonstrated positive clinical outcomes for patients with mechanical chronic low back pain. The device received CE mark approval in Europe (2016), Australian approval (2019), and FDA approval in the US (2020). Clinical trials such as ReActiv8-B and RESTORE have shown efficacy, leading to expanded insurance coverage including recent exclusive coverage by Anthem Blue Cross/Blue Shield[5][6]. Five-year follow-up data and comparative studies between age groups have been published[4].

Therapeutic areas: Rheumatology
Modalities: DeviceImplantable neurostimulation system
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

ReActiv8

Commercial

Indications: Chronic mechanical low back pain

Partnerships

None publicly disclosed with major pharmaceutical or biotech companies; key partnerships are primarily with investors and payers such as Anthem Blue Cross/Blue Shield for reimbursement coverage

Beyond the preview

Go deeper on Mainstay Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mainstay Medical.

Explore the full profile